Pharmacology of Hypertension 1 Flashcards

1
Q

How is hypertension?

A

Persistently raised arterial blood pressure
Can be further classified at essential or secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the normal ranges of blood pressure?

A

Systolic - 90-120mmHg
Diastolic - 60-80mmHg
MAP - 70-93mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different stages of hypertension?

A

SP/DP
Stage 1: 140/90 until
Stage 2: 160/100
Stage 3: Systolic above 180 or Diastolic above 120

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What range of blood pressures is considered pre-hypertension?

A

Systolic 120-139
Diastolic 80-89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the different varients of hypertension?

A

Isolated systolic hypertension
Isolated disatolic hypertension
Mixed hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the features of isolated systolic hypertension?

A

Systolic BP above 140
But disatolic pressure remain 90 or below
Results in a high pulse pressure
This is the most common variant and normally occurs due to a loss of elasticity of blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the features of isolated diastolic hypertension?

A

Systolic BP is below 140
DBP is above 90
Reduced pulse pressure
Least common variant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the criteria for mixed hypertension?

A

Systolic BP above 140
Diastolic BP above 90

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prevalence of different types of hypertension?

A

ISH: MHT: IDH
4:2;1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between essential and secondary hypertension?

A

Essential is more common (90%) no known cause (idiopathic)

Secondary is less common (10%), has a known cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some of the causes of secondary hypertension?

A

Renal disorders
Endocrine
Drug induced
Pregnancy - pre-eclampsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What endocrine conditions can cause secondary hypertension?

A

Primary hyperaldosteronism - (conns syndrome) too musch aldosterone inc Na+ and water reabsoprtion
Phaeochromocytoma - tumour on adrenal medulla - increase NA and A secretion (Sympathetic)
Cushing syndrome - cortisol inc adrenergic receptor expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the drug induced methods of hypertension?

A

Cocaine - Sympathetic NS
Iatrogenic - combined oral contraceptive, glucocorticoids. (increase renin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some potential exogenous factors causing hypertension?

A

Diet, smoking, stress, obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some endogenous factors causing hypertension?

A

Metabolic/hormonal
Renal (RAAS)
CNS
Arterial
Ethnicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are some consequences of hypertension?

A

Increased risk of cardiovascular disorders including:
Coronary artery disease
Stroke
Heart failure
Peripheral arterial disease
Vascular dementia
Chronic Kidney disease

Decreasing BP by 10mmHg closer to nrmal range has a 10% reduction in the risk of cardiovascular adverse events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some of the pathophysiological mechanisms controlling BP?

A

Cardiac output
Peripheral resistance
Autonomic Nervous System
Endothelium
Vasoactive peptides
Renin-angiotensin-aldosterone system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do you calculate mean arterial blood pressure?

A

MAP = Cardiac output x Total peripheral Resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How to calculate cardiac output?

A

CO = SV*HR
CO = MAP/SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What physic factors may influence hypertension in essential hypertension?
CO, SVR, MAP

A

Most patients have a normal CO and increased TPR - may be due to loss of arteriolar resistance, lack of elastic tissue, underused become less elastic and loss of smooth muscle

Very early - TPR may be normal and CO increased, leads to chronic adaptive response to inc TPR to decrease CO, irreversible and causes hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the basic principles of how ANS regulates heart function linked to hypertension?

A

Noradrenaline
Beta 1 receptors
SAN - inc HR
Contractily cells - increased contractility
Leads to increased cardiac output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How does the ANS regulate vessel function?

A

Arteriole tone mainly controls TPR (beta 2, alpha 1 - vasoconstriction and vasodilation)
Venular tone regulates Central venous pressure - (decreased when veins dilated, decreased preload, decreased CO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the short term regulation of blood pressure and flow?

A

The baroreceptor reflex mediated through the autonomic nervous system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is control of the autonomic nervous system link to essential hypertension?

A

Little evidence to implicate adrenaline as a cause of essential hypertension
However, inhibition of the ANS can provide symptomatic relief for patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How is the endothelium indicated in essential hypertension?

A

Is dysregulated in essential hypertension.
Endothelial cells produce vasoactive agents
A decrease in NO, PGI2 and increase in endothelin may contribute to hypertension (Vasoconstriction of blood vessel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How does nitric oxide cause vasodilation of blood vessels?

A

Increase guanylyl cyclase activity
Increase GTP conversion to cGMP
Increase Protein Kinase G
(activates myosin phosphatase resulting in dephosphorylation of myosin light chain)
Resulting in smooth muscle relaxation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the effect of an atheroma on blood vessel diameter mediators?

A

Atheroma - decreases NO production (vasodilator) - resulting in maintained vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the effects of sodium nitroprusside on blood vessel diameter?

A

Increase NO levels (vasodilator)
Used in hypertensive emergencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the effect of sildenafil on blood vessel diameter?

A

Inhibits PDE5
Results in increased levels of cGMP
Promotes smooth muscle relaxation
Vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the effects of prostacylin PGI2 on blood vessel diameter?
How is this utilised in the therapeutic world?

A

Causes vasodilation of blood vessels
Structural analgues such as iloprost can be used to treat pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How does endothelin affect blood vessel diameter?
How is this utilised in therapeutic world?

A

Is produced by endothelial cells
Cause vasoconstriction
ET receptor antagonists (macitentan) used to treat pulmonary hypertension

32
Q

How does achetylcholine cause vasodilation?

A

Acts on endothelial cells to cause NO release
Activates guanylyl cyclase
Increase conversation of GTP to cGMP
Increase PKG activity
Results in smooth muscle relaxation

33
Q

What are some different vasoactive peptides?

A

Bradykinin
Natiuretic peptides (ANP from atria, BNP from brain ventricles and CNP from endo and heart)
Vasopressin

34
Q

How does bradykinin affect blood vessel diameter?
How is this ultilsed therapeutically?

A

Released from mast cells mainly during inflammation
Cause vasodilation
ACE inhibitors prevent the breakdown of bradykinin
resulting in increased vasodilation, combat hypertension.

35
Q

What is the role of natriuretic peptides in controlling blood pressure?

A

Result in increase Na+ and H2O excretion by dilating afferent and constricting efferent arteriole in glomerulus.
Acts on NRP1 receptor - is a transmembrane guanylyl cylcase - inc cGMP - results in smooth muscle relaxation of afferent arteriole.

36
Q

What is the result of a malfunctional NRP1 receptor?

A

Natriuretic peptides (ANPetc) have no effect
Results in fluid Retention and hypertension.

37
Q

What is the affect of vasopression on blood pressure?

A

ADH
Released from posterior pituitary gland
Causes vasoconstriction via V1 receptors
V2 receptors in DCT/CD to increase permeability to water - increase water reabsoprtion
Also in counter current multiplier an urea recycling.
Increase blood volume.

38
Q

What is the role of the Renin-Angiotensin-Aldosterone System in essential hypertension?

A

Regulates longer term blood volume and SRV hence blood pressure
Is not considered a cause of essential hypertension with many patients having low levels of renin and AT-2.
Local ‘paracine’ RAAS systems may regulate regional blood flow and contribute to essential hypertension.
But can be targeted to cause relief

39
Q

How is angiotensin 1 converted to angiotensin 2?

A

ACE enzyme cleavage of C-terminal dipeptide

40
Q

Angiotensin 2 is a what as At1 receptors?

A

Full agonist

41
Q

What are the pharmacological features of ACE1?

A

ACE is transmembrane, anchored extracellular (most EF).
Widely expressed
Two functional independent catalytic sites with different physiological functions (not just ACE enzyme)
Each contain Zn2+ metalloproteinases
also cleaves bradykinin and GnRH - therefore ACE inhibitors can have negative effects.

42
Q

What are the properties of ACE2 enzymes?

A

Single pass transmembrane domain
Widely expressed
One catalytic domain (Zn2+ metalloproteinase)
Cleaves 1 amino acid from angiotensin 2 to produce AT(1-7)
These are antagonists for angiotensin 2

ACE2 is also the SARS-Cov-2 cell entry point.

43
Q

What are the features of the AT1 receptor?
What effects does it bring about when activated?

A

GPCR
Widely expressed in liver, kideny, adrenal gland, lung etc
Activated by AT-II (angiotensin 2)
Causes
- vasoconstriction (smooth muscle contraction)
- SANS stimulation central and peripheral
- aldsoterone release from zona glomerulosa
- ADH release
- tubular Na+ reabsoprtion in PCT
- endothelin release in endothelial cells.

44
Q

What is the difference between AT1/AT2 and AT-I and AT-II?

A

AT1/2 - angiotensin receptors
AT-I / II - angiotensin peptides

45
Q

What is the pharmacology of aldosterone?

A

Is a steroid/ mineralcorticoid
Full agonist at intracellular mineralcorticoid receptor in principle cells of the DCT

46
Q

What are the features of the mineral corticoid receptor that aldosterone acts on?

A

Is an intracellular nuclear hormone receptor
Expressed in epithelial with high electrical resistance e.g distal kidney tubular cells
Selecitlvy changes transcription
Increases transcription of ENaCs and Na+/K+ ATPase
Increase water reabsoprtion and Na+ reabsoprtion to increase blood volume.

47
Q

What are the features of ENaCs related to blood volume?

A

Widely expressed especially in distal kident tubules
Increased expression of ENaC on apical membrane
Leads to increased Na+ permeability
Increased Na+ reabsorption from the tubular lumen into cell
This is the rate limiting stage for salt reabsoprtion in this part of the nephron
Therefore increase increase Na+ reabsoprtions.

48
Q

How does sodium reabsoprtion link to arterial blood pressure?

A

Increase Na+ reabsoprtion
Increased water reabsoprtion
Increased ECF volume
Increased stroke volume
increased cardiac output
Increased Arterial blood pressure

49
Q

What is amiloride?

A

A channel blocker
Blocks ENaCs in the DCT.
Prevents reabsorption of Na+ hence water.

50
Q

What are the features of the Na+/K+ pump related to RAAS?

A

Multimeric ATP-dependent active transporter
Expressed throughout the renal tubule
Sustains Na+/K+ gradient across membrane (regulate intracellular and intersistial conc)

51
Q

What is the role of cardiac glycosides in relation to RAAS?

A

Example is digoxin
Inhibit Na+ K+ Pump
prevent Na+ hence water reabsoprtion - decrease blood volume.

52
Q

What is Liddle Syndrome?

A

A rare autosomal dominant disorder
Mutations in ebta and gamma subunit of ENaC prevents channel internalisation and degradation
Results in overexpression of ENaCs leading to increased Na+ reabsoprtion
Resulting in severe hy[ertension at an early age
Treat with ENaC channel blockers

53
Q

What is the appropriate treatment for Liddle syndrome?

A

Amiloride
ENaC channel blockers

54
Q

What drug class is spironolactone?

A

Potassium sparing diuretic
Competitive antagonist of nuclear mineralcorticoid receptors in the DCT - prevent action of aldosterone.

55
Q

What is the use of ganglion blockers as drugs?

A

No longer used
Target nicotinic receptors on the post synaptic membrane are channels blockers.
Prevent action potential generation on post-synaptic neruons
Inhibits the parasympathetic and sympathetic nervous system transmission of impulses
Prevents hypertension.

56
Q

What are the different classifications of drugs that may be used as hypertensive drugs?

A

Diuretics : thiazides, loops and K+ sparing
Renin inhibitor
ACE inhibitor
Angiotensin Receptor Blockers
Calcium Channel blockers
Beta blockers
Centrally acting alpha 2 agonists
Vasodilators

57
Q

What different vasodilators can be used to prevent hypertension?

A

Nitroprusside - NO donor
Phentolamine - non-selecitve alpha adrenergic antagonist
Prazosin - selective alpha 1 adrenergic antagonist
Minoxidil - potassium channel opener
Hydralzine - MOA unknown - acts direclty on smooth muscle

58
Q

**What is the use of an aliskiren in the treatment of hypertension?

A

Class: renin inhibitor
Chemistry: non peptide small molecule
Pharmacology: is a competitive inhibitor of renin
Physiology: decreases conversion of angiotensinogen to angiotensin 1 - knock on = loss of RAAS effects
Clinical: essential hypertension

59
Q

What naming indicates a renin inhibitor?

A
  • Ren suffix
60
Q

What is the use of enalapril in treating hypertension?

A

Class: ACE inhibitor
Chemistry: small molecule, pr-drug converted from as ester by hepatic esterases to a carboxylic acid called enalaprilat
Pharmacology: competitive inhibitor of ACE
Physiology: decreased conversion of angiotensin 1 to angiotensin 2, knock on = loss of RAAS effects
Clinical: essential hypertension and heart failure
Side effects: also prevents breakdown of bradykinin may lead to a cough

61
Q

Are ACE inhibitors pro-drugs?

A

Most are esters and must be converted to carboxylic acids by hepatic esterases
Only captoprile and lisinopril are not pro-drugs

62
Q

What naming indicates an ACE inhibitor?

A
  • pril suffix
63
Q

What is the use of Valsartan in treating hypertension?

A

Class: is a angiotensin receptor blocker (ARB)
Chemistry: small molecule
Pharmacology: is a competitive antagonist at AT1 receptors
Physiology: angiotensin 2 unable to bind to receptors, loss of RAAS effects
Clinical: essential hypertension, heart failure

64
Q

Suggest why an angiotensin receptor blocker may be given over an ACE inhibitor?

A

ACE inhibitor:
ACE breaks down bradykinin, when this is inhibited bradykinin accumulates and can cause a cough

ARB
ACE still functional, so no cough.

65
Q

Describe the structure of a voltage gated calcium ion channel.

A

Has a principle alpha subunit with four homologous 6 alpha helicical transmembrane spanning regions.
S4 region contains positively charged residues important for activation
Subunit 3 to 4 loop has lysine residues acts to inactivate the channel
Has variable regulatory beta, gamma and alpha 2 delta subunits,

66
Q

How do gabapentin and pregabalin target the VGCa2+ channel?

A

Target the alpha 2 delta auxillaary subunits
Treat anxiety and epilepsy.

67
Q

What is the physiological role of a VGCa2+ Channel?

A

Normall there is a large difference between free Ca2+ conc in the ECF and the activated Ca2+ in the cytoplasm, this creates a concentration gradient for Ca2+ to rapidly move into the cell
Depolarisations open the VGCa2+ channel and causes Ca2+ to rush into the cytoplasm.

This has a role in:
Cardiac action potential
Smooth/skeletal muscle contraction
Endocrine/insulin secretion
Neurotransmitter release.

68
Q

Give an overview of type 1 voltage gated Calcium ion channels?

A

Type 1 or L type - has three subtypes - Long open duration, inactivate slowly
subtype 1 - skeletal muscle
subtype 2 - excitable cells, cardiac, smooth muscle, endocrine cells
subtype 3 - excitable cells (SAN/AVN), endocrine cells
Subtype 4 - retina

69
Q

Give an overview of the different types of voltage gated calcium ion channels.

A

Type 1 - long timer open, highly responsive to voltage
Type 2 - P/Q, N or R type, some response to voltage
Type 3 - T - low response to voltage, are open transiently, inactivate rapidly.

70
Q

What are the different types of calcium channel blockers?

A

All target L-type channels
Differ by their chemistry
1. Phenylalkylamines
2. Benzothiazepines
3. Dihydropyridnes

71
Q

What is the use of phenylalkylamines?

A

Example Verapamil
Channel blocker of L type VGCa2+ channels
Used as an anti-dysrhythmic

72
Q

What is the use of benzothiazepines?

A

Example - diltiazem
Channel blocker of inactivated state L type VGCa2+ channel
used to treat angina

73
Q

What si the use of dihydropyridines?

A

Examples: amlodipine or nifedipine
Are gating inhibitors (allosteric modulation of the channel causes it to close)
This modification inhibits voltage-dependent activation (rather than directly preventing it)
This stabilises the unresponsive state of the channel.
Clinical use to treat hypertension/angina.

74
Q

What are the different classes of anti-dysrhthmic drugs?

A

Vaughan-Williams Classification
Class 1 - local anaesthetics
Class 2 - Beta blockers
Class 3 - K+ Channel blockers
Class 4 - Ca2+ channel blockers

75
Q

What is the main clinical distinction between dihydropyridines v phenylalkamines?

A

Dihydropyridines are more vessel selective
Phenylalkalimes are more cardio-selective.

76
Q

What is the use of amlodipine in treating hypertension?

A

Class: calcium channel blocker
Chemistry: small molecule, dihydropyridine
Pharmacology: preferentially affects smooth muscle over cardiac muscle, allosteric regulator, acts as gating inhibitor
Physiology: modification stabilises inactivated channel state (prevents opening) when depolarisation occurs - this stabilises the hyperpolarised cell state
This decreases Ca2+ influx into cytoplasm - prevents smooth muscle contraction
Results in vasodilation
Clinical: essential hypertension, angina.

77
Q

Why are dihydropyridines selective for smooth muscle?
Compared to phenyalkylamines which prefer cardiac muscle

A

DHP binding is highly voltage dependent
Higher affinity for inactivated state
Vessels: are depolarised more in a continuous state of contraction in order to maintain vascular tone, results in more open m and closed H gate - higher affinity for inactivation state change.
Compared to cardiac muscle which depolarised and repolarises rapidly so less time spent in inactivation state of channel.

Phenylalylamines are not as voltage dependent.